Skip to main content

Advertisement

Log in

The importance of patient selection for lung volume reduction

  • Interventional Pulmonology (L Seijo, Section Editor)
  • Published:
Current Pulmonology Reports Aims and scope Submit manuscript

Abstract

COPD is one of the main causes of morbidity and mortality worldwide. It is a progressive disease for which there is currently no cure, limiting activities of daily living and worsening patients’ quality of life. Emphysema involves the destruction of the lung parenchyma, the main pathogenic manifestation of which is pulmonary hyperinflation, which limits airflow and exercise impairment. In recent years, several treatments have been developed to reduce lung volume and improve ventilatory mechanics. Surgical treatment was used initially, though the high rate of mortality and perioperative complications has caused this treatment be reserved for a select subset of patients. More recently, various endoscopic devices have appeared. There are several ongoing studies aimed at assessing the efficacy and safety of these procedures. Not all patients diagnosed with emphysema are candidates for this treatment and accurate patient selection is essential for achieving positive outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–128.

    Article  PubMed  Google Scholar 

  2. Murray CJ, Lopez AD. Measuring the global burden of disease. N Engl J Med. 2013;369(5):448–57. doi:10.1056/NEJMra1201534.

    Article  CAS  PubMed  Google Scholar 

  3. Halbert RJ, Natoli JL, Gano A, et al. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006;28:523–32.

    Article  CAS  PubMed  Google Scholar 

  4. Miravitlles M, Soler-Cataluña JJ, Calle M, et al. Spanish guideline for COPD (GesEPOC). Update 2014. Arch Bronconeumol. 2014;50 Suppl 1:1–16. doi:10.1016/S0300-2896(14)70070-5.

    PubMed  Google Scholar 

  5. Vestbo J, Hurd S, Agusti A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Resp Crit Care Med. 2013;187:347–65.

    Article  CAS  PubMed  Google Scholar 

  6. Kemp SV, Polkey MI, Shah PL. The epidemiology, etiology, clinical features, and natural history of emphysema. Thorac Surg Clin. 2009;19:149–58.

    Article  PubMed  Google Scholar 

  7. Klooster K, ten Hacken NH, Hartman JE, et al. Determining the role of dynamic hyperinflation in patients with severe chronic obstructive pulmonary disease. Respiration. 2015;90:306–13.

    Article  PubMed  Google Scholar 

  8. Gelb AF, Gutierrez CA, Weisman IM, et al. Simplified detection of dynamic hyperinflation. Chest. 2004;126:1855–60.

    Article  PubMed  Google Scholar 

  9. O’Donnell DE. Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2006;3(2):180–4.

    Article  PubMed  Google Scholar 

  10. Brantigan OC, Mueller E. Surgical treatment of pulmonary emphysema. Am Surg. 1957;23:789–804.

    CAS  PubMed  Google Scholar 

  11. Fishman A, Martinez F, Naunheim K, et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med. 2003;348:2059–73.

    Article  PubMed  Google Scholar 

  12. Criner GJ, Cordova F, Sternberg AL, et al. The NETT: part I. Lessons learned about emphysema. Am J Respir Crit Care Med. 2011;184:763–70.

    Article  PubMed  Google Scholar 

  13. Herth F, Gompelmann D, Stanzel F, et al. Treatment of advanced emphysema with emphysematous lung sealant (AeriSeal®). Respiration. 2011;82:36–45.

    Article  CAS  PubMed  Google Scholar 

  14. Herth FJ, Valipour A, Shah PL, et al. Segmental volume reduction using thermal vapour ablation in patients with severe emphysema: 6-month results of the multicentre, parallel-group, open-label, randomised controlled STEP-UP trial. Lancet Respir Med. 2016;4(3):185–93. doi:10.1016/S2213-2600(16)00045-X.

    Article  PubMed  Google Scholar 

  15. Strange C, Herth F, Kovitz K, et al. Design of the Endobronchial Valve for Emphysema Palliation Trial (VENT): a non-surgical method of lung volume reduction. BMC Pulm Med. 2007;7:10.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Davey C, Zoumot Z, Jordan S, et al. Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi study): a randomised controlled trial. Lancet. 2015;386(9998):1066–73. doi:10.1016/S0140-6736(15)60001-0.

    Article  PubMed  Google Scholar 

  17. Klooster K, Ten Hacken N, Hartman JE. Endobronchial valves for emphysema without interlobar collateral ventilation. N Engl J Med. 2015;373:2325–35. In this study authors show the importance of collateral ventilation assessment in patient selection for endobronchial valves treatment.

    Article  CAS  PubMed  Google Scholar 

  18. Klooster K. Endobronchial valve treatment versus standard medical care in patients with emphysema without interlobar collateral ventilation (the STELVIO-Trial). Am J Respir Crit Care Med. 2015;191:A6312.

    Google Scholar 

  19. Eberhardt R, Herth FJ, Radhakrishnan S, Gompelmann D. Comparing clinical outcomes in upper versus lower lobe endobronchial valve treatment in severe emphysema. Respiration. 2015;90:314–20. doi:10.1159/000437358.

    Article  PubMed  Google Scholar 

  20. Eberhardt R, Gompelmann D, Schuhmann M, et al. Complete unilateral vs partial bilateral endoscopic lung volume reduction in patients with bilateral lung emphysema. Chest. 2012;142:900–8.

    Article  PubMed  Google Scholar 

  21. Eberhardt R, Gerovasili V, Kontogianni K, et al. Endoscopic lung volume reduction with endobronchial valves in patients with severe emphysema and established pulmonary hypertension. Respiration. 2015;89(1):41–8.

    Article  PubMed  Google Scholar 

  22. Hillerdal G. Case report: bilateral endoscopic volume reduction in a woman with severe emphysema. Clin Respir J. 2015. doi: 10.1111/crj.12441.

  23. Wood DE, Nader DA, Springmeyer SC. The IBV Valve Trial: a multicenter, randomized, double-blind trial of endobronchial therapy for severe emphysema. J Bronchology Interv Pulmonol. 2014;21(4):288–97. doi:10.1097/LBR.0000000000000110.

    Article  PubMed  Google Scholar 

  24. Koegelenberg C, Slebos DJ, Shah P, et al. Time for the global rollout of endoscopic lung volume reduction. Respiration. 2015;90:430–40. doi:10.1159/000439311.

    Article  PubMed  Google Scholar 

  25. Gompelmann D, Eberhardt R, Herth F. Endoscopic volume reduction in COPD—a critical review. Dtsch Arztebl Int. 2014;111:827–33. doi:10.3238/arztebl.2014.0827.

    PubMed  PubMed Central  Google Scholar 

  26. Hartman JE, Klooster K, Ten Hacken NH, Slebos DJ. Treatment of emphysema using bronchoscopic lung volume reduction coil technology: an update on efficacy and safety. Ther Adv Respir Dis. 2015;9(5):251–9. doi:10.1177/1753465815589904.

    Article  PubMed  Google Scholar 

  27. Deslee G, Klooster K, Hetzel M, et al. Lung volume reduction coil treatment for patients with severe emphysema: a European multicentre trial. Thorax. 2014;69:980–6.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Zoumot Z, Kemp SV, Singh, et al. Endobronchial Coils for severe emphysema are effective up to 12 months following treatment: medium term and cross-over results from a randomised controlled trial. PLoS One 10(4): e0122656. doi:10.1371/journal.pone.0122656.

  29. Slebos DJ, Hartman JE, Klooster K. Bronchoscopic coil treatment for patients with severe emphysema: a meta-analysis. Respiration. 2015;90:136–45.

    Article  PubMed  Google Scholar 

  30. Hartman JE, Klooster K, Gortzak K. Long-term follow-up after bronchoscopic lung volume reduction treatment with coils in patients with severe emphysema. Respirology. 2015;20(2):319–26. doi:10.1111/resp.12435.

    Article  PubMed  Google Scholar 

  31. Deslée G, Mal H, Dutau H, et al. Lung volume reduction coil treatment vs usual care in patients with severe emphysema: the REVOLENS Randomized Clinical Trial. JAMA. 2016;315(2):175–84. doi:10.1001/jama.2015.17821. This randomized study compares coil treatment vs usual care in 6 month and one year follow-up.

    Article  PubMed  Google Scholar 

  32. Naunheim KS, Wood DE, Krasna MJ, et al. Predictors of operative mortality and cardiopulmonary morbidity in the National Emphysema Treatment Trial. J Thorac Cardiovasc Surg. 2006;131(1):43–53.

    Article  PubMed  Google Scholar 

  33. Eberhardt R, Gompelmann D, Herth FJ, et al. Endoscopic bronchial valve treatment: patient selection and special considerations. Int J Chron Obstruct Pulmon Dis. 2015;10:2147–57. doi:10.2147/COPD.S63473.

    PubMed  PubMed Central  Google Scholar 

  34. Herth FJ, Slebos DJ, Rabe K, Shah P. Endoscopic lung volume reduction: an expert panel recommendation. Respiration. 2016;91:241–50. doi:10.1159/000444090. This publication summarizes patient characteristics for endoscopic lung volume reduction and also the different diagnostic tests necessary for assessment and patient selection.

    Article  PubMed  Google Scholar 

  35. Zoumot Z, Lomauro A, Aliverti A, et al. Lung volume reduction in emphysema improves chest wall asynchrony. Chest. 2015;148(1):185–95.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Puente-Maestu L, Palange P, Casaburi R, et al. Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement. Eur Respir J. 2016;47(2):429–60. doi:10.1183/13993003.00745-2015.

    Article  PubMed  Google Scholar 

  37. Redelmeier DA, Bayoumi AM, Goldstein RS, Guyatt GH. Interpreting small differences in functional status: the six minute walk test in chronic lung disease patients. Am J Respir Crit Care Med. 1997;155(4):1278–82.

    Article  CAS  PubMed  Google Scholar 

  38. Milanese G, Silva M, Sverzellati N. Lung volume reduction of pulmonary emphysema: the radiologist task. Curr Opin Pulm Med. 2016;22(2):179–86. doi: 0.1097/MCP.0000000000000252.

    Article  PubMed  Google Scholar 

  39. Doellinger F, Huebner RH, Kuhnigk JM, et al. Lung volume reduction in pulmonary emphysema from the radiologist’s perspective. Rofo. 2015;187(8):662–75. doi:10.1055/s-0034-1399540.

    Article  CAS  PubMed  Google Scholar 

  40. Alves GR, Marchiori E, Irion KL. The effects of dynamic hyperinflation on CT emphysema measurements in patients with COPD. Eur J Radiol. 2014;83(12):2255–9. doi:10.1016/j.ejrad.2014.08.014.

    Article  PubMed  Google Scholar 

  41. Fiorelli A, Petrillo M, Vicidomini G. Quantitative assessment of emphysematous parenchyma using multidetector-row computed tomography in patients scheduled for endobronchial treatment with one-way valves. Interact Cardiovasc Thorac Surg. 2014;19(2):246–55. doi:10.1093/icvts/ivu107.

    Article  PubMed  Google Scholar 

  42. Pizarro C, Ahmadzadehfar H, Essler M, et al. Effect of endobronchial valve therapy on pulmonary perfusion and ventilation distribution. PLoS One. 2015;10(3):e0118976. doi:10.1371/journal.pone.0118976.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Gompelmann D, Eberhardt R, Slebos DJ. Diagnostic performance comparison of the Chartis system and high-resolution computerized tomography fissure analysis for planning endoscopic lung volume reduction. Respirology. 2014;19(4):524–30. doi:10.1111/resp.12253.

    Article  PubMed  Google Scholar 

  44. Diso D, Anile M, Carillo C, et al. Correlation between collateral ventilation and interlobar lung fissures. Respiration. 2014;88:315–9. doi:10.1159/000363538.

    Article  PubMed  Google Scholar 

  45. Herzog D, Thomsen C, Poellinger A. Outcomes of endobronchial valve treatment based on the precise criteria of an endobronchial catheter for detection of collateral ventilation under spontaneous breathing. Respiration. 2016;91(1):69–78. doi:10.1159/000442886.

    Article  PubMed  Google Scholar 

  46. Schuhmann M, Raffy P, Yin Y, et al. Computed tomography predictors of response to endobronchial valve lung reduction treatment. Comparison with Chartis. Am J Respir Crit Care Med. 2015;191(7):767–74. doi:10.1164/rccm.201407-1205OC.

    Article  PubMed  Google Scholar 

  47. Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013;62 suppl 25:D34–41.

    Article  PubMed  Google Scholar 

  48. Faisal A, Zoumot Z, Shah PL, et al. Effective bronchoscopic lung volume reduction accelerates exercise oxygen uptake kinetics in emphysema. Chest. 2016;149(2):435–46.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Javier Flandes.

Ethics declarations

Conflict of interest

Iker Fernadnez-Navamuel, Javier Flandes, and Javier Alfayate report having received financial support for research from PneumRx.

Human and animal rights and informed consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Interventional Pulmonology

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Flandes, J., Alfayate, J. & Fernández-Navamuel, I. The importance of patient selection for lung volume reduction. Curr Pulmonol Rep 5, 159–167 (2016). https://doi.org/10.1007/s13665-016-0153-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13665-016-0153-9

Keywords

Navigation